LifeStance Health Group, Inc.

Equities

LFST

US53228F1012

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.2 ^USD	+0.65%		+8.58%	-20.82%

Mar. 12	LifeStance Health Appoints Teresa DeLuca to Its Board of Directors	CI
Mar. 06	Jefferies Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Buy Rating	MT

LifeStance Health Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 28, 2024 at 06:17 am EST

LifeStance Health Group, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 280.6 million compared to USD 229.4 million a year ago. Net loss was USD 45 million compared to USD 46.7 million a year ago.

Latest news about LifeStance Health Group, Inc.

LifeStance Health Appoints Teresa DeLuca to Its Board of Directors	Mar. 12	CI
Jefferies Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Buy Rating	Mar. 06	MT
Lifestance Health Group Insider Sold Shares Worth $923,391, According to a Recent SEC Filing	Mar. 05	MT
Goldman Sachs Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Neutral Rating	Mar. 04	MT
UBS Adjusts LifeStance Health Group Price Target to $9 From $7, Maintains Neutral Rating	Feb. 29	MT
Barclays Adjusts LifeStance Health Group Price Target to $8 From $7, Maintains Underweight Rating	Feb. 29	MT
Sector Update: Health Care Stocks Decline Late Afternoon	Feb. 28	MT
Sector Update: Health Care Stocks Softer Wednesday Afternoon	Feb. 28	MT
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise	Feb. 28	MT
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise	Feb. 28	MT
Transcript : LifeStance Health Group, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
LifeStance Health Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
LifeStance Health Group, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024	Feb. 28	CI
LifeStance Health Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Sector Update: Health Care Stocks Rise in Late Afternoon	Feb. 01	MT
Sector Update: Health Care Stocks Rise in Thursday Afternoon Trading	Feb. 01	MT
Sector Update: Health Care	Feb. 01	MT
LifeStance shares fall after Hindenburg takes short position	Feb. 01	RE
LifeStance Health Group Shares Fall After Hindenburg Research Report	Feb. 01	MT
LifeStance Health Group Shares Fall After Hindenburg Research Report	Feb. 01	MT
LifeStance Health Appoints Ujjwal Ramtekkar as Chief Medical Officer	Jan. 19	MT
Lifestance Appoints Ujjwal Ramtekkar as Chief Medical Officer, Effective January 22, 2024	Jan. 19	CI
Goldman Sachs Adjusts Price Target on LifeStance Health to $8 From $9, Maintains Neutral Rating	Nov. 22	MT
JPMorgan Adjusts LifeStance Health Group's Price Target to $8 From $10, Maintains Neutral Rating	Nov. 17	MT
UBS Cuts LifeStance Health Group's Price Target to $7 From $10, Keeps Neutral Rating	Nov. 09	MT

Chart LifeStance Health Group, Inc.

Duration

Period

More charts

Company Profile

LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

Sector

Healthcare Facilities & Services

Calendar

2024-05-09 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for LifeStance Health Group, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

6.2 USD

Average target price

8.786 USD

Spread / Average Target

+41.70%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
LIFESTANCE HEALTH GROUP, INC.	-20.82%	2.37B
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.62%	29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-2.28%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.40%	11.77B
FRESENIUS MEDICAL CARE AG	+0.18%	11.72B
DAVITA INC.	+27.44%	11.71B

Other Healthcare Facilities & Services